Karen Luise Lang Selected Research

Cucurbitacins

1/2017	Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model.
4/2016	Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen Luise Lang Research Topics

Disease

3	Neoplasms (Cancer) 01/2017 - 05/2012
3	Lung Neoplasms (Lung Cancer) 01/2017 - 10/2015
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Pleurisy (Pleuritis) 09/2007
1	Inflammation (Inflammations) 09/2007

Drug/Important Bio-Agent (IBA)

3	cucurbitacin BIBA 01/2017 - 05/2012
2	CucurbitacinsIBA 01/2017 - 04/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Cyclin B1IBA 04/2016
1	Biological ProductsIBA 04/2016
1	TriterpenesIBA 04/2016
1	Substance PIBA 09/2007
1	CarrageenanIBA 09/2007
1	Adenosine DeaminaseIBA 09/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007
1	Peroxidase (Myeloperoxidase)IBA 09/2007
1	Histamine (Histamine Dihydrochloride)FDA Link 09/2007
1	BradykininIBA 09/2007

Therapy/Procedure

2	Therapeutics 01/2017 - 10/2015
1	Drug Therapy (Chemotherapy) 10/2015